| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |